July 25, 2012 08:00 ET

Equity Research on Eli Lilly & Co. and Pfizer Inc. - Drug Manufacturers Focusing on HIV and Alzheimer's

NEW YORK, NY--(Marketwire - Jul 25, 2012) - has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Drug Manufacturers - Major industry and are offering free analytical research on Eli Lilly & Co. (NYSE: LLY) and Pfizer Inc. (NYSE: PFE). Register with us now to have free access to these research reports. Simply click on the link below.

For major players in the drug manufacturers industry, such as Eli Lilly & Co. and Pfizer Inc., patent expiries have created significant challenges to grow revenues and earnings over the last little while. A number of blockbuster drugs are now being generically produced, and branded drug companies have been focusing on finding the next big cure. Get your free reports on Eli Lilly & Co. and Pfizer Inc. at There is no commitment to join. is the Ultimate Trading Environment for investors. If you are considering owning Eli Lilly & Co. and Pfizer Inc. then you should sign up for a free membership and our complimentary reports today. Over the last 5 years our returns outpaced any of the major indexes. Sign up today by clicking on the link below to find out what you are missing.

Two specific areas that companies have been focusing their attentions on are HIV and Alzheimer's. Several companies, including Pfizer, have been working on preventative treatments for HIV in healthy people. Studies are ongoing, and the company or companies that can come out with the most effective product could be well positioned moving forward. Pfizer Inc. report is accessible for free by registering today at

The treatment of Alzheimer's is another potentially lucrative area, and one in which Eli Lilly has been devoting plenty of time and effort. The company has been developing the drug solanezumab, and will be reporting its results in the fall. Eli Lilly & Co. report is accessible for free by registering today at

The two Drug Manufacturers - Major stocks research reports are available for free by signing up now on the link below.


Shine's Rooms is the brain child of David Shine, a 13 year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.

To view our disclaimer, visit this link

Contact Information